Table 2.
Immunohistochemistry analysis of SQCLC patient samples.
| Features | Cases | ANXA1 | P value | |
|---|---|---|---|---|
| — | + | |||
| Gender | ||||
| Male | 63 | 50 (79.4%) | 13 (20.6%) | 0.359 |
| Female | 18 | 16 (88.9%) | 2 (11.1%) | |
| Age | ||||
| ≥60 | 59 | 50 (84.7%) | 9 (15.3%) | 0.2155 |
| <60 | 22 | 16 (72.7%) | 6 (27.3%) | |
| Lymph node metastasis | ||||
| Yes | 37 | 30 (81.1%) | 7 (18.9%) | 0.9322 |
| No | 44 | 36 (81.8%) | 8 (18.2%) | |
| Degree of differentiation | ||||
| I+II | 64 | 52 (81.3%) | 12 (18.8%) | 0.9171 |
| III | 17 | 14 (82.4%) | 3 (17.6%) | |
| Clinical stage | ||||
| I+II | 56 | 46 (82.1%) | 10 (17.9%) | 0.8978 |
| III+IV | 24 | 20 (83.3%) | 4 (16.7%) | |
SQCLC: squamous cell lung cancer, P values are calculated according to Chi-square test.